BAX FRAUD ALERT: Jakubowitz Law is Investigating Baxter International Inc. in Connection with Potential Violations of Federal Securities Laws
NEW YORK, June 12, 2023 /PRNewswire/ -- Jakubowitz Law announces that an investigation into potential securities fraud allegations has commenced on behalf of shareholders of Baxter International Inc. ("Baxter" or "the Company") (NYSE: BAX)
To be contacted by a member of our team, fill out the form:
https://claimyourloss.com/securities/baxter-class-action-loss-submission-form/?wire=4
Further details on the investigation: Baxter is a multi-national healthcare company, primarily focusing on products designed to treat kidney disease and other chronic and acute medical conditions. Recent announcements suggest that Baxter materially misrepresented and/or concealed the true nature and severity of supply chain problems it was encountering and the impact they were having on the Company's current and expected earnings. Baxter's failure to disclose the Company's true problems relating to its supply chain deceived investors about Baxter's true financial health and earnings.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (628) 895-0423
F: (212) 537-5887
SOURCE Jakubowitz Law
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article